Zero-time Exercise for Depression
1 other identifier
interventional
14
1 country
1
Brief Summary
This study will examine the feasibility and effectiveness of a new lifestyle-integrated exercise, viz. Zero-time Exercise (ZTEx), for the management of depressive symptoms in Chinese adults in Hong Kong. ZTEx refers to the integration of simple strength- and stamina-enhancing physical activity into daily life, which can be done anytime, anywhere and by anyone. Depression is often accompanied by a tendency to sedentary behaviours and sleep disturbances, and sedentary lifestyles is associated with depression. The conventional psychological treatment approach for depression, viz. Cognitive Behavioural Therapy (CBT), emphasises the relationship between activity and mood. One of the treatment components in CBT for depression, viz. Behavioural Activation (BA), aims to promote activity engagement that are reinforcing and consistent with the long-term goals in reducing sedentary behaviour and increasing physical activity. The simple and brief ZTEx uses a foot-in-the-door approach to initiate simple behaviour change as an entry-level step for facilitating BA for participants with depression. A pilot randomized controlled trial (RCT) has shown some evidence on the effectiveness of ZTEx on improving insomnia. However, investigators have found no RCT on the effectiveness of ZTEx for the management of depressive symptoms.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable depression
Started May 2019
Shorter than P25 for not_applicable depression
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 18, 2019
CompletedFirst Posted
Study publicly available on registry
January 22, 2019
CompletedStudy Start
First participant enrolled
May 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
August 31, 2019
CompletedMarch 11, 2020
March 1, 2020
3 months
January 18, 2019
March 9, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in the Patient Health Questionnaire (PHQ-9)
The PHQ-9, a 20-item questionnaire used for screening, diagnosing, monitoring and measuring the severity of depression, which scores each of the nine DSM-IV criteria as "0" (not at all) to "3" (nearly every day). PHQ-9 scores of 5, 10, 15, and 20 represents mild, moderate, moderately severe and severe depression
Baseline, 1-week post-treatment and 4-week post treatment
Secondary Outcomes (7)
Change in Hospital Anxiety and Depression Scale (HADS)
Baseline, 1-week post-treatment and 4-week post treatment
Change in Insomnia Severity Index (ISI)
Baseline, 1-week post-treatment and 4-week post treatment
Change in Multidimensional Fatigue Inventory (MFI)
Baseline, 1-week post-treatment and 4-week post treatment
Change in International Physical Activities Questionnaire - Chinese version (IPAQ-C)
Baseline, 1-week post-treatment and 4-week post treatment
Change in Short Form (Six-Dimension) Health Survey - The Chinese (Hong Kong) Version (SF-6D)
Baseline, 1-week post-treatment and 4-week post treatment
- +2 more secondary outcomes
Study Arms (2)
Treatment group
EXPERIMENTALZero-time Exercise group
Waitlist group
NO INTERVENTIONInterventions
A 2-hour group ZTEx training once per week for 2 consecutive weeks (totally 4 hours)
Eligibility Criteria
You may qualify if:
- Hong Kong residents aged 18-65 years
- Cantonese language fluency
- Patient Health Questionnaire (PHQ-9) score ≥ 10 and ≤ 14; and
- Willingness to provide informed consent and comply with the trial protocol.
You may not qualify if:
- Pregnancy;
- Have high levels of suicidal ideation (referral information to professional services will be provided);
- Unstable psychotropic drugs within 2 weeks before study entry and throughout the treatment phase;
- Current involvement in psychotherapy for depression;
- Having unsafe conditions and are not recommended for exercising by physicians; and
- Major psychiatric, medical or neurocognitive disorders that would make participation infeasible or interfere with the adherence to physical exercising.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Chinese University of Hong Kong
Shatin, Hong Kong
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
January 18, 2019
First Posted
January 22, 2019
Study Start
May 1, 2019
Primary Completion
July 31, 2019
Study Completion
August 31, 2019
Last Updated
March 11, 2020
Record last verified: 2020-03